Cell calcium

Activation of blood vessel lining cells reduces bone formation by blocking bone growth signals through GREM1

Updated

Abstract

Systemic Yoda1 administration reduced the abundance of CD31EMCN-type H vessels and disrupted trabecular bone microarchitecture.

  • Activation of PIEZO1 may impair the relationship between blood vessels and bone formation.
  • Yoda1 treatment suppressed osteogenic gene expression and alkaline phosphatase activity in bone cells.
  • RNA sequencing indicated a shift in endothelial cells toward an l-type phenotype and increased expression of BMP antagonists.
  • Endothelial-derived GREM1 could inhibit osteoblast differentiation induced by BMP4 through signaling between cells.
  • The findings suggest potential risks associated with targeting PIEZO1 for bone regeneration, emphasizing the need for careful consideration of dosage and treatment duration.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Haoran Zhang reports equipment, drugs, or supplies was provided by National Facility for Protein Science in Shanghai. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free